The Clorox Company
CLX stock is flourishing, buoyed by its well-orchestrated strategic maneuvers. Profiting from a perfect blend of deft pricing strategies and astute cost savings programs, it has been on a winning streak. The latest IGNITE strategy, a seamless extension of the 2020 Strategy, is driving an accelerated pace of innovation across all facets of its operations. Clorox’s shares have catapulted by 18.6% in the last six months, overshadowing the industry’s 10.1% uptick. Bolstering its position is a commendable Growth Score of B, enhancing the allure of this Zacks Rank #3 (Hold) entity.
Digging Deeper
Clorox’s sturdy pricing mechanisms and prudent cost-saving initiatives have effectively countered soaring manufacturing and logistical costs. This prowess manifested in a remarkable gross margin expansion of 730 basis points (bps) year over year in the second quarter of fiscal 2024. This marks the fifth consecutive quarter of gross margin fortification, propelled by shrewd pricing tactics and cost efficiencies, albeit slightly dampened by adverse foreign exchange headwinds. For fiscal 2024, a further 200 bps year-over-year expansion in gross margins is on the horizon.
The IGNITE strategy remains the lodestar for Clorox. This blueprint maps out ambitious financial goals, including a 3-5% surge in net sales growth, an EBIT margin hike of 25-50 bps, and a free cash flow yield of 11-13% of sales.
The company’s management unveiled a streamlined operational model, christened as Reimagine Work, under the aegis of the IGNITE strategy. This model is engineered to rev up the company’s efficiency, ushering in a nimble, more efficacious organization. Designed to revamp operations in the realms of supply chain, digital commerce, innovation, and brand building, this transformation anticipates a spurt in agility. This metamorphosis is poised to augment the company’s agility in navigating shifting consumer dynamics, hasten innovation adoption, and ultimately bolster cash flows through generated cost savings. Upon full implementation, the company envisages annual cost savings in the ballpark range of $75 million to $100 million.
In a paradigm-shifting move, Clorox has laid out plans to inject a substantial $500 million in the coming years into transformative technologies and processes. Kickstarting in the first quarter of fiscal 2022, these investments encompass a strategic overhaul of the company’s enterprise resource planning system, a transition toward a cloud-based architecture, and the installation of a suite of digital technologies. Of the $500 million earmarked for this transformative journey, a substantial 55% will be accounted for as incremental operating expenditures within selling and administrative expenses, duly adjusted from the reported earnings per share.
Promising Stocks to Explore
The Chef’s Warehouse
CHEF, a purveyor of niche food products, currently flaunts a Zacks Rank #2 (Buy). Sporting a trailing four-quarter earnings surprise averaging 3.2%, CHEF appears to be a promising pick. Projections indicate an anticipated 8.7% growth in sales and a 4.7% uptick in earnings for the current fiscal year compared to the year-ago figures.
Vital Farms Inc.
VITL, renowned for its range of pasture-raised culinary treats, carries a Zacks Rank of 2. With a remarkable trailing four-quarter average earnings surprise of 155.4%, VITL stands out in the crowd. The Zacks Consensus Estimate foresees vigorous growth of 18.6% in sales and an impressive 35.6% surge in earnings for the current financial year compared to the previous year.
Utz Brands Inc.
UTZ, celebrated for its diverse spectrum of salty indulgences, currently holds a Zacks Rank of 2. With a modest trailing four-quarter average earnings surprise of 2.6%, UTZ exudes promise. Estimates depict a prospective 15.8% earnings growth for the current financial year relative to the prior year.
For the full article from Zacks.com, click here.
